Halozyme Therapeutics HALO revenue climbs 375 YoY despite steep earnings miss investors parse guidance amid cost concerns What the smart money sees in Accenture ACN that retail does not Builds on Momentum 20260507 Eaton ETN Business Model Review Q4 2025 Earnings Beat Estimates DLNGA Dynagas Pref reports quarterly results preferred unit holders await dividend update as LNG shipping rates stabilize